Phenotypic screening for metallo-β-lactamases and extended-spectrum β-lactamases in <i>Pseudomonas aeruginosa</i> using the VITEK-2 AST-N443 and Phoenix NMIC-486 cards. [PDF]
Mancini S +8 more
europepmc +1 more source
<i>In vitro</i> activity of aztreonam-nacubactam and cefepime-nacubactam against a global collection of clinically important Gram-negative Bacilli collected in 2021-2023. [PDF]
Karlowsky JA +4 more
europepmc +1 more source
Inoculum-dependent activity of contemporary β-lactam agents against carbapenemase- producing Enterobacterales. [PDF]
Sahu TK, Gadkari P, Rathored J.
europepmc +1 more source
In vivo pharmacokinetic analysis of meropenem/vaborbactam during continuous venovenous haemodialysis
Wesley D Kufel +5 more
openaire +2 more sources
Complete genome sequences of KPC-producing <i>Klebsiella pneumoniae</i> isolates pre- and post-development of meropenem/vaborbactam resistance. [PDF]
Ozer EA +5 more
europepmc +1 more source
Real-world use of novel β-lactams in immunologically vulnerable patients: insights from an Italian retrospective cohort. [PDF]
Bognetti M +14 more
europepmc +1 more source
Novel β-Lactam/β-Lactamase Inhibitors Versus Best Available Therapy on the Mortality-Related Carbapenem-Resistant Enterobacterales Infection: A Systematic Review and Meta-Analysis. [PDF]
Al Shammari BR.
europepmc +1 more source
Emergence of KPC-producing <i>Pseudomonas aeruginosa</i> in Spain: insights into an outbreak and resistance to the novel carbapenem/β-lactamase inhibitor combinations imipenem/relebactam and meropenem/vaborbactam. [PDF]
Pérez-Rodríguez G +13 more
europepmc +1 more source
In vitro activity of cefiderocol against Burkholderia cepacia complex and Burkholderia gladioli clinical isolates from cystic fibrosis patients in the United States. [PDF]
Mojica MF +6 more
europepmc +1 more source
Avibactam-based combinations for the treatment of multidrug resistant Gram-negative bacilli infections. [PDF]
Tiseo G +4 more
europepmc +1 more source

